Promethera Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Promethera Biosciences's estimated annual revenue is currently $5M per year.
- Promethera Biosciences's estimated revenue per employee is $77,500
- Promethera Biosciences's total funding is $149.1M.
Employee Data
- Promethera Biosciences has 65 Employees.
- Promethera Biosciences grew their employee count by 10% last year.
Promethera Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Operations & CMC | Reveal Email/Phone |
2 | Office Manager | Reveal Email/Phone |
3 | Clinical Study Manager / Lead CRA | Reveal Email/Phone |
4 | Clinical Study Manager | Reveal Email/Phone |
5 | Senior Scientist R&D | Reveal Email/Phone |
6 | General Manager Japan Branch | Reveal Email/Phone |
7 | Secouriste industriel | Reveal Email/Phone |
8 | GMP expert | Reveal Email/Phone |
9 | Administrative Assistant | Reveal Email/Phone |
10 | Technicien logistique | Reveal Email/Phone |
Promethera Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Promethera Biosciences?
Promethera Biosciences is a global innovator in liver therapeutics whose mission is to bring life-saving treatments to reduce the need for liver transplantation. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. In addition to our cell-based pipeline we develop antibody technologies, such as the antiTNF-R1 antibody Atrosimab, to complement and diversify our therapeutic options. We are a team of international experts operating out of facilities in Mont-Saint-Guibert, Belgium, Durham, NC, USA, Tokyo, Japan and Basel, Switzerland.
keywords:N/A
$149.1M
Total Funding
65
Number of Employees
$5M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Promethera Biosciences News
... Ultragenyx Pharmaceutical Inc, Promethera Biosciences SA, Unicyte AG, Lucane Pharma SA, Translate Bio Inc, Selecta Biosciences Inc.
Lucane Pharma SA, PhaseRx Inc, Promethera Biosciences SA, Selecta Biosciences Inc, Translate Bio Inc, Ultragenyx Pharmaceutical Inc.
Grifols Therapeutics, Promethera Biosciences, RHEACELL, Versantis AG, Martin pharmaceuticals. Report overview: * The report analyses regional...
Promethera Biosciences SA, a Mont-Saint-Guibert, Belgium-based global innovator in cell-based medicines and liver diseases, added €7.5m in funding to its recent €39.7m Series D financing. The round was led by new investors Sony Innovation Fund by IGV and Pegasus Tech Ventures, with MEDIPAL Hold ...
Other Companies in Mont Saint Guibert
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $25.8M | 162 | 8% | N/A |